STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
Democratic senators said RFK Jr.'s recent explanation of how he disposed of a financial stake in Gardasil litigation conflicts with his earlier answers
U.S. senators have questioned Robert F. Kennedy Jr.'s explanation for disposing of a financial stake in litigation involving Merck's Gardasil vaccine, reports Reuters. A group of Democrats sent a letter to the secretary, questioning whether his son received his share of the $50 million Merck settled for in Gardasil vaccine litigation.
They also inquired if Kennedy agreed to recuse himself from HHS decisions related to Gardasil or other vaccine-related policymaking. The FDA has approved a new treatment, Imaavy, for a rare blood disorder called warm autoimmune hemolytic anemia (wAIHA). Imaavy is the first FDA-approved drug for treating wAIHA in patients aged 12 and older who have previously been treated with steroids.
The approval is based on a mid-to-late-stage study involving 115 adults, and the drug is administered via intravenous infusion every four weeks at a dose determined by the patient's weight.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
